Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-01, Stock:NVS, The news for the past five days is as follows:
2019-07-25: NEWS1: Astra, Roche Join Rivals in Boosting Forecasts as New Drugs Prosper.
2019-07-26: NEWS1: Will Strong Jakafi Sales Drive Incyte (INCY) Q2 Earnings?.NEWS2: Will Strong Jakafi Sales Drive Incyte (INCY) Q2 Earnings?.NEWS3: S&P Stays Above 3,000 as Market Pulls Back.NEWS4: S&P Stays Above 3,000 as Market Pulls Back.NEWS5: Will Strong Jakafi Sales Drive Incyte (INCY) Q2 Earnings?.NEWS6: S&P Stays Above 3,000 as Market Pulls Back.NEWS7: Dianne Feinstein’s Husband Richard Blum Switches to Selling FedEx Stock From Buying.
2019-07-29: NEWS1: Novartis heart drug fails trial, curbing growth prospects.
2019-07-30: NEWS1: Here's What You'll Want to Know About Incyte's Impressive Q2 Results.NEWS2: Here's What You'll Want to Know About Incyte's Impressive Q2 Results.NEWS3: Big drugmakers trade Peninsula plant as part of larger deal.NEWS4: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS5: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS6: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS7: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS8: Incyte (INCY) Q2 Earnings Beat Estimates, Revenues Up Y/Y.NEWS9: Lilly (LLY) Q2 Earnings Beat, New Drugs Drive Sales, Stock Up.NEWS10: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS11: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS12: Are Investors Undervaluing Novartis (NVS) Right Now?.NEWS13: Are Investors Undervaluing Novartis (NVS) Right Now?.NEWS14: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS15: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS16: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS17: Are Investors Undervaluing Novartis (NVS) Right Now?.NEWS18: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS19: Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments.NEWS20: Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments.NEWS21: FOCUS-Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments.
2019-07-31: NEWS1: Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat.NEWS2: Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat.NEWS3: Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised.NEWS4: Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised.NEWS5: Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat.NEWS6: Gilead (GILD) Q2 Earnings & Sales Beat, Sales Guidance Raised.

Answer: Rise